Publications by authors named "Jesus Zoco"

Claim this Profile
E
Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial.
Diana Alexandra Echeverria Proano, Fengcai Zhu, Xiaodong Sun, Jesús Zoco, Jyoti Soni

Hum Vaccin Immunother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.
Hamid Emamekhoo, Mark R Olsen, Bradley C Carthon, Alexandra Drakaki, Ivor J Percent, Jesus Zoco

Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial.
Scott S Tykodi, Lucio N Gordan, Robert S Alter, Edward Arrowsmith, Michael R Harrison, Jesus Zoco

J Immunother Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Outcomes With Nivolumab in Patients With Wild-Type Advanced Melanoma.
Caroline Robert, Georgina V Long, Benjamin Brady, Caroline Dutriaux, Anna Maria Di Giacomo, Jesús Zoco

J Clin Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Alzheimer risk genes determine the microglia response to amyloid-β but not to TAU pathology.
Annerieke Sierksma, Ashley Lu, Renzo Mancuso, Nicola Fattorelli, Nicola Thrupp, Jesus Zoco

EMBO Mol Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis